$6.05
0.498.81%
Last update: Nov 10, 8:51 AM
Strata Critical Medical Inc
SRTANASDAQ
Strata Critical Medical rose 24.7% from $4.85 to $6.05, ahead of the S&P 500's +10.5%. Its worst day was Jan 26 (−9.1%), and its low came Nov 20 at $4.03.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.12 missed the $-0.02 estimate on $49.3M revenue (est. $58.5M); FY revenue guidance of $185.0M–$195.0M against the $183.8M consensus.
0.0% · S&P 500 +1.6%
Story events cover the past 12 months · Times ET
Strata Critical Medical closed at its lowest level of the year, 16.9% below where the year started.
−4.5% · S&P 500 −1.5%
Strata Critical Medical shares rose 13.9%, while the S&P 500 rose 0.2%.
+13.9% · S&P 500 +0.2%
Strata Critical Medical shares rose 14.4%, while the S&P 500 rose 0.7%.
+14.4% · S&P 500 +0.7%
Strata Critical Medical shares fell 9.1%, while the S&P 500 rose 0.5%.
−9.1%, the year's worst day · S&P 500 +0.5%
EPS of $-0.06 missed the $-0.04 estimate on $66.8M revenue (est. $60.4M); FY revenue guidance of $260.0M–$275.0M against the $266.5M consensus.
+6.9% · S&P 500 −0.9%
EPS of $0.03 beat the $-0.04 estimate on $67.4M revenue (est. $63.7M); FY revenue guidance of $260.0M–$275.0M against the $269.0M consensus.
+10.6% · S&P 500 +1.4%
Strata Critical Medical closed at its highest level of the year, 33.4% above where the year started.
+3.4% · S&P 500 +0.6%
EPS of $-0.12 missed the $-0.04 estimate on $72.5M revenue (est. $66.9M); FY revenue guidance of $285.0M–$295.0M against the $273.0M consensus.
+0.4% · S&P 500 +1.8%
EPS of $-0.09 missed the $0.01 estimate on $74.1M revenue (est. $72.8M); FY revenue guidance of $285.0M–$295.0M against the $290.8M consensus.
+3.7% · S&P 500 +0.3%
Where it ended: a close of $6.05 on Nov 9, 2026. Up next: Q4 2026 earnings on Mar 2, 2027 (EPS est. $0.01, revenue est. $76.1M).
Nothing in the past 12 months.
All SRTA dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SRTA and SPY from Benzinga historical bars. Not investment advice.
